medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2013, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2013; 22 (1)

Flujometría. Automonitorización del asma en el paciente pediátrico. Revisión sistemática

Cano ZR

Language: Spanish
References: 43
Page: 11-18
PDF size: 187.95 Kb.


ABSTRACT

Introduction: Asthma is a cronic infl amatory disease of airways which cells, cellulary elements play an important action. (GINA). Thera are associated risk factors with the increased asthma that rises morbidity, mortality, school absent of pediatric patient.
New guidelines recomend the portable peak flowmeter for measure the peak expiratory flow.
Is an accesible and useful tool for evaluate pulmonary function in asthmatic patients in ambulatory way.
Objective: Improve the conditions of the asthmatic patient and demonstrate that the measurement of expiratory peak flow by the peak flow meter reduces the urgencies visits, school absent and mantain a good disease control.
Results: The peak flowmeter is an useful tool in ambulatory evaluation of pediatric astha patient because of the agreement between spirometry (gold standard) and peak expiratory flowmeter
Conclusion: It's necessary treat and control asthma by an repoducible and objective way. Using portable tolos in school, home, physician office. The peak flowmeter its the most reliable tool for evaluate the in an ambulatory way patient with asthma.


REFERENCES

  1. Global strategy for asthma management and prevention 2008 (update). Pp. 2-13. http://www.ginasthma.org

  2. Grad R et al. Peak flow measurements in children with asthma: what happens at school? J Asthma 2009; 46(6): 535-540.

  3. Secretaría de Salud, México; Dirección de Epidemiología. Información Epidemiológica de Morbilidad 2005 Versión Ejecutiva. http://www.dgepi.salud.gob.mx pp21

  4. Zahran H. Predictor of asthma self-management education among children and adults-2006-2007, behavioral risk factor surveillance system asthma call-back survey. Journal of Asthma 2012; 49: 98-106.

  5. Lugogo NL, Kraft M. Epidemiology of asthma. Clin Chest Med 2006; 27: 1-15.

  6. Leung D et al. In utero smoke exposure diminishes the benefit go inhaled corticosteroids. J Allergy Clin Imnmunol 2012; 126(3): 481.

  7. Weitzman M, Gortmaker S, Walker DK et al. Maternal smoking and childhood asthma. Pediatrics 1990; 85: 505-511.

  8. Strachan DP, Cook DG. Parental smoking and childhood asthma: longitudinal and case control studies. Thorax 1998; 53: 201-212.

  9. Eisner M, Yelin EH, Henke J et al. Environmental tobacco smoke and adult asthma: the impact of changing exposure status on health outcomes. Am J Respir Crit Care Med 1998; 158: 170-175.

  10. Lazarus SC, Boushey HA, Fahy JV et al. Long acting beta-2, agonist monotherapy versus continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001; 285: 2583-2593.

  11. Larj MJ, Bleecker ER. Effects of beta 2-agonist on airway tone and bronchial responsiveness. J Alergy Clin Immunol 2002; 110: 304-312.

  12. Khetsuriani N et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007: 314-320.

  13. Kraft M. The role of bacterial infections in asthma. Clin Chest Med 2000; 21: 301-313.

  14. Martin RJ. Kraft M, Chu HW et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107: 595-601.

  15. Centers for Disease Control. National Center for Health Statics, 2002.

  16. Evans III R, Mullaly DI, Wilson RW et al. National trends in the morbidity and mortality of asthma in the US. Chest 1987; 91: 65S-73S.

  17. Lynch B et al. Impact of delay in asthma diagnosis on health care service use. Allergy Asthma Proc 2010; 31(4): 48-52.

  18. Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 2002; 109: S482-489.

  19. Laforest L, Yin D, Kocevar VS et al. Association between asthma control in children and loss of work days by caregivers. Ann Allergy Asthma Immunol 2004; 93: 265-271.

  20. Calhoun SL et al. Prevalence and risk factors of excessive daytime sleepiness in a community sample of young children: the role of obesity, asthma, anxiety/depression, and sleep. SLEEP 2011; 34(4): 503-507.

  21. Martínez MA. Asma y estado asmático. CIE-10° REV. J45, J46. Epidemiología No. 30 Volumen 21 Semana 30 del 25 al 31 julio de 2004: 1-3.

  22. López GA, Marqués AL. Uso de los medidores del flujo espiratorio máximo (FEM) en el asma. Arch Bron- Coneumol 1994; 30: 301-306.

  23. Stewart LJ. Pediatric asthma. Prim Care Clin Office Pract 2008; (35): 25-40.

  24. Alcock SM, Mamum M, Prescott RJ, Connolly CK. Symptoms and pulmonary function in asthma care: chart construction and use in asthma care. Ann Allergy Asthma Immunol 1998; 818(6): 552-562.

  25. Jain P, Kavuru MS. Utility of peak expiratory flow monitoring. Chest 1998; 114(3): 861-876.

  26. Clark NM, Evans D, Mellins RB. Patient use of peak flow monitoring. Am Rev Respir Dis 1992; 145: 722-725.

  27. Grad R et al. Peak flow measurements in children with asthma: what happens at school? J Asthma 2009; 46(6): 535-540.

  28. Won Hee Seo et al. The standard range of peak expiratory flow rates of Korean children. Asian Pac J Allergy Immunol 2011; 29: 143-149.

  29. Taylor MR. Asthma: audit of peak flow rate guidelines for admission and discharge. Arch Dis Child 1994; 70: 432-434.

  30. McCarren M, Zalenski RJ, McDermott M. Predicting recovery from acute asthma in an emergency diagnostic and treatment unit. Acad Emerg 2000; 7(1): 28-35.

  31. Douma WR, van der Mark TW, Folgering HT et al. Mini-Wright peak flow meters are reliable after 5 years use. Eur Respir J 1997; 10: 457-459.

  32. Nolan S, Tolley E, Leeper K, Strayhorn Smith V. Peak expiratory flow associated with change in positioning of the instrument: comparison of five peak flow meters. J Asthma 1999; 36(3): 291-294.

  33. H. Koyama, K. Nishimura et al. Comparison of four types of portable peak flow meters (Mini-Wright, Assess, Pulmo-graph and Wright Pocket meters). Resp Med 1998; (92): 505-511.

  34. Beasley R, Cushley M, Holgate ST. A self-management plans in the treatment pf adult asthma. Thorax 1989; 44: 200-204.

  35. Charlton I, Charlton G, Broomfield J et al. Evaluation of peak flow and symptoms only self-management plans for control of asthma in general practice. BMJ 1990; 301: 1355-1359.

  36. Jones KP, Mullee MA, Middleton M et al. Peak flow based asthma self management: a randomized controlled study in general practice: British Thoracic Society Research Committee. Thorax 1995; 50: 851-857.

  37. Taylor MR. Asthma: audit of peak flow rate guidelines for admission and discharge. Arch Dis Child 1994; 70: 432-434.

  38. Gregg I, Nunn AJ. Peak expiratory flow in symptomless elderly smokers and ex-smoker. BMJ 1989: 1071-1072.

  39. Ortega CM y cols. Pruebas de función pulmonar en pediatría. Bol Med Hosp Infant Mex 1997: 47-53.

  40. Hogg JC. The pathology of asthma. Asthma physiology, immunopharmacology and treatment. Londres: Academic Press 1993: 17-25.

  41. Cóte J, Cartier A. Compliance with peak expiratory flow readings per day on the estimation of diurnal variation. Thorax 1998; 53(9): 790-792.

  42. Renaud L, Lau LC. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.

  43. Zahran HS, Person CJ, Moorman JE. Predictors of asthma self-management education among children and adults-2006-2007. Behavioral risk factor surveillance system asthma call-back survey. Journal of Asthma 2012; 49(1): 98-106.




2020     |     www.medigraphic.com